Jeffrey G. Lamothe

Insider Reports History

Location
Seattle, WA
Signature
/s/ SoYoung Kwon, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeffrey G. Lamothe:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aptevo Therapeutics Inc. EVP, COO Common Stock (post-reverse split May ACTIVE) 6 $2 $0.3400 17 Jul 2025 Direct
Aptevo Therapeutics Inc. EVP, COO Restricted Stock Unit 17,300 06 Aug 2025 Direct

Insider Reports Filed by Jeffrey G. Lamothe

Symbol Company Period Transactions Value $ Form Type Role Filing Time
APVO Aptevo Therapeutics Inc. 06 Aug 2025 1 $0 4 EVP, COO 08 Aug 2025, 16:32
APVO Aptevo Therapeutics Inc. 17 Jul 2025 2 $0 4 EVP, COO 21 Jul 2025, 16:35
APVO Aptevo Therapeutics Inc. 02 Mar 2025 4 $0 4 EVP, COO 04 Mar 2025, 16:35
APVO Aptevo Therapeutics Inc. 08 Aug 2024 4 $0 4 EVP, COO 09 Aug 2024, 16:33
APVO Aptevo Therapeutics Inc. 17 Jul 2024 1 $0 4 EVP, COO 19 Jul 2024, 16:35
APVO Aptevo Therapeutics Inc. 02 Mar 2024 4 $0 4 EVP, COO 05 Mar 2024, 16:12
APVO Aptevo Therapeutics Inc. 28 Jan 2024 2 $0 4 EVP, COO 30 Jan 2024, 18:04
APVO Aptevo Therapeutics Inc. 08 Aug 2023 4 $0 4 EVP, COO 10 Aug 2023, 08:41
APVO Aptevo Therapeutics Inc. 03 Mar 2023 4 $0 4 EVP, COO 07 Mar 2023, 15:44
APVO Aptevo Therapeutics Inc. 29 Jan 2023 2 $0 4 CFO 30 Jan 2023, 12:04
APVO Aptevo Therapeutics Inc. 09 Aug 2022 3 $0 4 CFO 10 Aug 2022, 16:08
APVO Aptevo Therapeutics Inc. 07 Jun 2022 1 $0 4 CFO 07 Jun 2022, 17:25
APVO Aptevo Therapeutics Inc. 04 Mar 2022 1 $0 4 CFO 04 Mar 2022, 17:11
APVO Aptevo Therapeutics Inc. 29 Jan 2022 2 $0 4 SVP and CFO 01 Feb 2022, 17:00